- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Instruments
Snapshot for NuVasive Inc (NUVA)
| Open: | 23.1700 | Day's Range: | 22.9000 - 23.2300 | Volume: | 285,298 |
|---|---|---|---|---|---|
| Previous Close: | 23.1000 | 52wk Range: | 12.3500 - 25.9900 | 1-Yr Rtn: | +24.68% |
Key Statistics for NUVA
| Current P/E Ratio (ttm) | 60.8947 |
|---|---|
| Estimated P/E(12/2013) | 22.7532 |
| Relative P/E vs. SPX | 3.7352 |
| Earnings Per Share (USD) (ttm) | 0.3800 |
| Est. EPS (USD) (12/2013) | 1.0170 |
| Est. PEG Ratio | 1.4928 |
| Market Cap (M USD) | 1,023.48 |
| Shares Outstanding (M) | 44.23 |
| 30 Day Average Volume | 370,211 |
| Price/Book (mrq) | 1.8824 |
| Price/Sale (ttm) | 1.6073 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/25/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for NUVA
Company Profile & Key Executives for NUVA
NuVasive, Inc. designs, develops, and markets products for the surgical treatment of spine disorders. The Company's products include Maximum Access Surgery (MAS) and Fusion products.
| Alexis V LukianovChairman/CEO | Keith C ValentinePresident/COO |
| Patrick W G MilesPresident:Global Products | Michael J LambertExec VP/CFO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
NUVA News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page